La Jolla, CA, United States of America

Toshiaki Maruyama

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 194(Granted Patents)


Company Filing History:


Years Active: 2007-2018

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Toshiaki Maruyama: Innovator in Cancer Treatment and Gene Amplification

Introduction

Toshiaki Maruyama is a prominent inventor based in La Jolla, California. He has made significant contributions to the fields of gene amplification and cancer treatment, holding a total of 10 patents. His innovative work focuses on developing methods that enhance the efficacy of therapies for chronic lymphocytic leukemia and other conditions.

Latest Patents

One of Maruyama's latest patents involves the preparation of gene-specific templates for use in single primer amplification. This disclosure relates to methods for creating engineered templates that facilitate the amplification of one or more antibody genes without the need for gene-specific primers. The templates engineered using these methods are particularly useful in a polymerase chain reaction setting, allowing for the specific amplification of antibody genes. Another notable patent addresses polypeptides and antibodies derived from chronic lymphocytic leukemia cells. This cancer treatment therapy aims to interfere with the interaction between CD200 and its receptor, thereby blocking immune suppression and promoting the eradication of cancer cells. The therapy includes the administration of novel antibodies, functional fragments, or fusion molecules that target cancer cells effectively.

Career Highlights

Throughout his career, Toshiaki Maruyama has worked with notable companies such as Alexion Pharmaceuticals, Inc. and Abwiz Bio, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Maruyama has collaborated with esteemed colleagues, including Katherine S. Bowdish and John R. McWhirter. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Toshiaki Maruyama's contributions to gene amplification and cancer treatment exemplify the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…